carfilzomib
FDA Approves Darzalex Faspro Plus Kd for RR Multiple Myeloma
The FDA approved daratumumab plus hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech) in combination with ...
DECEMBER 3, 2021
Trial Is Assessing KRd Versus KCd in Newly Diagnosed MM Pts
Chicago—As an induction therapy in newly diagnosed, relatively young patients with multiple myeloma (MM), ...
JUNE 30, 2017
Load more